diazonpharmaceuticals.com
Contact us
About company
Embedded in its novel mechanism of action, Diazon’s new generation onco-therapeutic DZ-2384 targets a proven therapeutic pathway in oncology, but one whose potential in modern cancer therapy has been severely restricted due to unacceptable toxicities.
Unknown
Unknown
Not verified company
